“…Asterisks indicate individuals who demonstrated reduction in SAI following lorazepam intake, reflecting the TIME main effect found in the two-way ANOVA. Long-latency afferent inhibition Baclofen ISI 1,9 = 0.631, P = 0.543 TIME 2,18 = 1.497, P = 0.252 ISI × TIME 2,18 = 1.125, P = 0.346 Placebo ISI 1,9 = 0.509, P = 0.610 TIME 2,18 = 0.896, P = 0.369 ISI × TIME 2,18 = 0.548, P = 0.588 Short-latency afferent inhibition Baclofen ISI 1,9 = 1.299, P = 0.284 TIME 1,9 = 0.884, P = 0.372 ISI × TIME 1,9 = 0.279, P = 0.610 Placebo ISI 1,9 = 0.297, P = 0.599 TIME 1,9 = 0.093, P = 0.767 ISI × TIME 1,9 = 2.557, P = 0.144 interneuron population within S1 that ultimately acts to disinhibit pyramidal neurons (DiCarlo & Johnson, 2000;Wood et al 2017). Disinhibition of S1 pyramidal neurons would allow for excitation of M1 pyramidal neurons via long-range connections throughout layers II/III (Amassian et al 1987) and V (Ferezou et al 2007;Aronoff et al 2010).…”